News
Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...
A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...
Explore Rash on Chest Pictures, Causes, Symptoms, Remedies and Treatment to identify your skin condition and find effective ...
The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.
I was fully covered in these hives, head to toe. Literally from the top of my head to the bottom of my feet,” said Rob ...
(WBRE/WYOU) — A pregnant goat “deliberately” hit by a car is on her way to a full recovery, officials say. According to ...
People are not born allergic to things, but they can be born with a genetic tendency to become allergic to things to which ...
Chris Brookes-Smith could have died from eating peanuts - but taking part in a clinical trial has changed his life.
Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...
Childhood food allergies can be life-threatening. Learn how to manage them with preparation, support, and informed strategies ...
The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results